[Drug induced lung injuries in Japanese population].
Kudo
Shoji
S
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D044466:Asian People; D001761:Bleomycin / Q000009:adverse effects; D000077156:Gefitinib; D020022:Genetic Predisposition to Disease; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects; D007564:Japan; D000077339:Leflunomide; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000235:genetics; D011650:Pulmonary Alveoli; D011799:Quinazolines / Q000009:adverse effects; D044469:Racial Groups
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D007555:Isoxazoles; D011799:Quinazolines; D001761:Bleomycin; D000077339:Leflunomide; D000077156:Gefitinib